# PharmOS Master Control Document

## Project Vision
Build a revolutionary AI-powered pharmaceutical innovation platform that will become the GitHub of drug discovery, starting with cardiovascular therapeutics and scaling to a billion-dollar ecosystem.

## Core Architecture

### 1. Platform Components
- **Research Hub**: AI-powered literature analysis and drug discovery
- **Collaboration Network**: Real-time team collaboration tools
- **Safety Analytics**: Predictive adverse event detection
- **Clinical Trials Management**: End-to-end trial optimization
- **Regulatory Compliance**: Automated FDA submission preparation

### 2. Technology Stack
- **Frontend**: React, TypeScript, TailwindCSS, WebGL for 3D molecular visualization
- **Backend**: Node.js/Express + Python/FastAPI hybrid architecture
- **Databases**: PostgreSQL (primary), MongoDB (documents), Redis (cache)
- **ML/AI**: TensorFlow, PyTorch, Transformers, RDKit for chemistry
- **Infrastructure**: Docker, Kubernetes, AWS/GCP multi-cloud

### 3. Key Features
- Real-time collaborative drug design
- AI-powered literature mining
- Predictive toxicity modeling
- Clinical trial matching
- Regulatory document generation
- Patent landscape analysis

### 4. Development Workflow
1. Feature branches from main
2. Automated testing on all PRs
3. Code review required
4. Staging deployment for validation
5. Production deployment with monitoring

### 5. Success Metrics
- 10,000 GitHub stars in 6 months
- 100,000 weekly active users
- $10M ARR potential
- 99.99% uptime capability
- <100ms API response time

### 6. Security & Compliance
- HIPAA compliant infrastructure
- End-to-end encryption
- Role-based access control
- Audit logging
- Data anonymization

### 7. Monetization Strategy
- Freemium model for researchers
- Enterprise licenses for pharma companies
- API access tiers
- Premium AI features
- Consulting services
